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Abstract 
Background: Medicinal plant and plant products have shown tremendous potentials and are used beneficially in the treatment of inflammation 
and in the management of diseases with significant inflammatory components. Many medicinal plants employed as anti-inflammatory and anti-
phlogistic remedies lack the gastro-erosive side effects of non-steroidal anti-inflammatory drugs (NSAID) or the plethora of unwanted side 
effects associated with steroidal anti-inflammatory drugs. In order to harness and optimise the applications of these herbs in inflammatory 
diseases, there is a need to understand how these herbs produce their anti-inflammatory actions. 
Materials and Methods: This paper is a review of some anti-inflammatory herbs and their molecular mechanisms of action. A literature search 
and analysis of published manuscript was employed to x-ray research findings that show how medicinal plants produce anti-inflammatory 
activities. 
Results: Many studies have shown that anti-inflammatory activities of herbal extracts and herb-derived compounds are mainly due to their 
inhibition of arachidonic acid (AA) metabolism, cyclo-oxygenase (COX), lipo-oxygenase (LOX), pro-inflammatory cytokines, inducible nitric 
oxide, and transcription activation factor (NF-κB). Some anti-inflammatory medicinal herbs are reported to stabilize lysosomal membrane and 
some cause the uncoupling of oxidative phosphorylation of intracellular signalling molecules. Many have also been shown to possess strong 
oxygen radical scavenging activities. 
Conclusion: Most of the mechanisms by which anti-inflammatory medicinal plants act are related and many herbal products have been shown 
to act through a combination of these molecular pathways. 
Key words: Medicinal plants, antiinflammatory, mechanism of action, molecular pathways. 
Introduction 
There are several proposed cellular actions or mechanisms explaining in vivo anti-inflammatory activity of medicinal plants. These 
mechanisms include antioxidative and radical scavenging activities, regulation of cellular activities of the inflammation-related cells: mast cells, 
macrophages, lymphocytes, and neutrophils (for instance, some inhibit histamine release from mast cells and others inhibit T-cell proliferation), 
modulation of the enzymatic activities of arachidonic acid (AA) metabolizing enzymes such as phospholipase A2 (PLA2), cyclooxygenase 
(COX), and lipoxygenase (LOX) and the nitric oxide (NO) producing enzyme, nitric oxide synthase (NOS) (Vane and Botting, 1987; Chen, 
2011). Inhibitions of these enzymes by anti-inflammatory medicinal plants products (AIMP) reduce the production of AA, prostaglandins (PG), 
leukotrienes (LT), and NO, which are crucial mediators of inflammation (Khanapure et al., 2007). Thus, the inhibition of these enzymes by 
AIMP is one of the important cellular mechanisms of anti-inflammation. In recent years, many lines of evidence support the idea that certain 
AIMP are the modulators of gene expression, especially the modulators of pro-inflammatory gene expression, thus leading to the attenuation of 
the inflammatory response. Here, we have highlighted the relevance of these mechanisms as they relate to the activities of herbal products used 
in the treatment of inflammation. 
1.0 Inhibition of Phospholipase A2 
During inflammatory response, arachidonic acid (AA), a precursor of eicosanoids, is released mostly from membrane lipids in cells. 
The enzyme responsible for this release is Phospholipase A2 (PLA2), although some portion is attributed to the combined action of 
phospholipase C and diacylglycerol lipase (Ito et al., 2002). AA mobilization by PLA2 and subsequent prostaglandins synthesis is considered to 
be a pivotal event in inflammation. Therefore, drugs that inhibit PLA2 thus block the cyclo-oxygenase (COX) and lipo-oxygenase (LOX) 
pathways in the AA cascade are effective in the treatment of inflammatory processes. PLA2 catalyses the hydrolysis of the acyl group attached 
to the 2-position of intracellular membrane phosphoglycerides which releases arachidonic acid from membrane phosphoglycerides. Arachidonic 
acid is the precursor of prostaglandins (PGs), thromboxanes, and leukotrienes. Some anti-inflammatory medicinal plants inhibit PLA2 (Figure 1) 
and this inhibition is mediated via lipocortine or by direct interaction with the enzyme itself. The former mechanism utilizes a protein known as 
lipocortine, the synthesis of which is induced by steroidal hormones and steroidal plant metabolite, triterpenoids (Barnes, 1998). The other 
mechanism involves a direct binding with the enzyme itself, a mechanism that is yet to be exploited in therapeutics but with great promise. It is 
known that betulinic acid, a triterpene act by direct binding to phospholipase A2 (Wiart, 2006). 
The inhibitory activity of several flavonoid derivatives against AA metabolizing enzymes was initially reported in 1980 (Bauman et 
al., 1980). Thereafter, investigators have studied the inhibitory effect of flavonoids on these enzymes (Kim et al., 2004). Up to date, many 
isoforms of PLA2 have been discovered (Murakami and Kudo, 2004). They are mainly classified into three large categories, secretory PLA2 
(sPLA2), cytosolic PLA2 (cPLA2), and calcium independent PLA2 (iPLA2). These PLA2s are distributed in wide varieties of tissues and cells. 
In some conditions, they are coupled to COXs depending on the cells and agonists used (Murakami and Kudo, 2004). For instance, group IIA 
sPLA2 was found in arthritic synovial fluid, and group IV cPLA2 are coupled to COXs and 5-LOX to produce eicosanoids (Murakami and 
Kudo, 2004). Therefore, a modulation of sPLA2 and/or cPLA2 activity is important in the control of inflammatory processes. 
The first flavonoid inhibitor of PLA2 to be identified was quercetin, which inhibited PLA2 from human neutrophils (Lee et al., 1982). 
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Quercetin was repeatedly found to inhibit PLA2 from several sources. It inhibited PLA2 from rabbit peritoneal neutrophils with an IC50 of 57100 
µM (Lanni and Becker, 1985). It was also demonstrated that quercetin selectively inhibited group II sPLA2 from Vipera russelli with less 
inhibition of PLA2 from porcine pancreas, PLA2-IB (Lindahl and Tagesson, 1993). While flavanones including flavanone, hesperetin, and 
naringenin showed less inhibition, flavonols such as kaempferol, quercetin, and myricetin were found to considerably inhibit snake venom PLA2, 
indicating an importance of the C-ring-2,3-double bond (Welton et al., 1986). 
In many other studies, other herbal extracts and phytoconstituents have been reported to exhibit significant anti-inflammatory effects through an 
inhibition of various PLA2. Extract of Trichilia catigua (Meliaceae) completely inhibited PLA2 at a concentration of 120 µg/ml (Barbosa et al., 
2004). Ethanol extract of Baccharis uncinella DC (Asteraceae) were reported to contains among other constituents two triterpenoids (oleanolic 
and ursolic acids) and one flavonoid (pectolinaringenin) which exhibited anti-inflammatory effects against inflammatory reactions induced by 
phospholipase A2 (from Crotalus durissus terrificus venom) (Zalewski et al., 2011). It was shown recently that the water extract of Aloe vera 
leaf skin (AVLS) extract exhibited anti- PLA2 activity with an IC50 = 0.22 mg/ml (Kammoun et al , 2011). Also recently, it was shown that the 
neuroprotective effect of Ginkgo biloba extract (EGb761) was mediated, at least in part, through inhibition of cytosolic cPLA2 activation (Zhao 
et al., 2011). In a study to evaluate the effects of the flavonoid, quercetin, on Crotalus durissus terrificus secretory phospholipase A2 (sPLA2), it 
was reported that the protein was chemically modified by treatment with quercetin, which resulted in modifications in the secondary structure as 
evidenced through circular dichroism (Kim et al., 2004). In addition, quercetin was able to inhibit the enzymatic activity and some 
pharmacological activities of sPLA2, including its antibacterial activity, its ability to induce platelet aggregation, and its myotoxicity by 
approximately 40% (Cotrim et al., 2011). Cochinchina momordica seed extract (SKMS10) was also shown to exhibit anti-inflammatory activities 
by down-regulating cPLA2 among other molecular mechanisms of action (Kang et al., 2009). 
 
Figure 1: The proposed mechanism of action of anti-inflammatory medicinal plants (AIMP). “ ” and “       ” denote enzyme inhibition 
and down-regulation of the expression, respectively. 
2.0 Inhibitors of cyclooxygenases (COX) 
COX that produces prostaglandins (PGs) and thromboxanes (TX) from arachidonic acid exists in two different isoforms (COX-1 and 
- 2). COX-1 is a constitutive enzyme existing in almost every cell type, catalysing the conversion of AA into cytoprotective PGs and blood pro-
aggregatory TXs. On the other hand, COX-2 is an inducible enzyme and in most cases causes the production of large amount of PGs 
(Needleman and Isakson, 1997). COX-2 is highly expressed in the inflammation-related cell types including macrophages and mast cells, when 
they are stimulated with pro-inflammatory cytokines and/or bacterial lipopolysaccharide (LPS) (Needleman and Isakson, 1997). Inhibition of 
both COX-1 and COX-2 has been found to be the molecular target of many anti-inflammatory herbal extracts and herb-.derived compounds 
(Figure 1). COX-2 that produces PGs is closely associated with inflammatory disorders of acute as well as chronic types. Actually, COX-2 
selective inhibitors possess anti-inflammatory activity with reduced side effects frequently seen with COX-1/COX-2 non-selective inhibitors 
(McMurray and Hardy, 2002). 
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Devil’s claw, Harpagophytum procumbens DC (Pedaliaceae) used in South Africa for the management of pain and inflammation is an 
example of medicinal plant whose anti-inflammatory activities is based on reported inhibition of COX (Kundu et al., 2005). Anti-inflammatory 
effects of seven lignans and one dihydrochalcone isolated from the leaves of two Lauraceae species (Pleurothyrium cinereum and Ocotea 
macrophylla), were found to be potent inhibitors of COX-2/5-LOX (Coy-B arrera and Cuca-Suarez, 2011). Ethyl acetate-soluble extract of the 
stems of Macrococculus pomiferus was found to inhibit COX-2 (Su et al., 2004). (S)-coriolic acid and (+/-)-glycerol 1-monolinolate isolated 
from ethylacetate-soluble extract of the seeds of Hernandia ovigera showed selective inhibitory activity with cyclooxygenase-2 (Jang et al., 
2004). The compound, 2, 4, 5-trimethoxybenzaldehyde isolated from Daucus carota seed extracts inhibited COX-2 enzyme very significantly at 
a concentration of 100 μg/ml (Momin et al., 2003). Some flavonoids such as luteolin, 3', 4'-dihyroxyflavone, galangin, and morin were found as 
inhibitors of COX (Bauman et al., 1980). When their structural activity relationships were compared, several flavone derivatives such as flavone 
and apigenin were found to be COX inhibitors, while some flavonol derivatives such as quercetin and myricetin were preferential LOX 
inhibitors. Also, certain flavonoids such as flavone, kaempferol, and quercetin were repeatedly found to be inhibitors of COX from rat peritoneal 
macrophages (Welton et al., 1986). After these reports, many studies have been done to figure out the inhibitory activity of flavonoids on COX, 
mostly COX-1. For instance, flavonoids such as quercetin and xanthomicrol were reported to inhibit sheep platelet COX-1; while the IC50 values 
of flavones such as cirsiliol, hypolaetin, and diosmetin were more than 100 µM (Ferrandiz et al., 1990). Furthermore, flavones and flavonols 
including chrysin, flavone, galangin, kaempferol, and quercetin were repeatedly revealed to inhibit TXB2 formation from mixed leukocyte 
suspension probably by COX-1 inhibition (Laughton et al., 1991). 
3.0 Inhibition of lipooxygenases (LOX) 
Arachidonate 5-lipoxygenase is the key enzyme in leukotriene biosynthesis and catalyses the initial steps in the conversion of 
arachidonic acid to biologically active leukotrienes. Leukotrienes are considered as potent mediators of inflammatory and allergic reactions, and 
regarding their pro-inflammatory properties the inhibition of 5-lipoxygenase pathway is considered to be interesting in the treatment of a variety of 
inflammatory diseases. Lipooxygenases (LOX) are present in leucocytes, tracheal cells, keratinocytes, and the epithelium of stomach and airways 
and they catalyse the introduction of a molecule of oxygen to the 5-position of AA to give the intermediate 5(S)- hydroxy- (6E, 8Z, 11Z, 14Z)-
eicosatetraenoic acid, 5-HETE, which is immediately followed by the re-arrangement of 5-HETE to leukotrienes. This is another target for anti-
inflammatory medicinal plants that inhibit the biogenesis of leukotrienes and 5-HETE (Figure 1). Medicinal plants that inhibit LOX hold some 
other useful therapeutic potential in the treatment of asthma, psoriasis, arthritis, allergic rhinitis, cancer, osteoporosis, and artherosclerosis. 
Table 1: Examples of some anti-inflammatory medicinal plants reported to inhibit the 5-lipoxygenase. 
Plant species/Family Extract/plant part used Active constituent/fraction References 
Longifolia nees (Asteracantha) Methanol seed extract   Kumar et al.,  
2000 
Gomphrena perennis L. 
(Amaranthaceae) 
Methanol extract of aerial 
part 
Ethylacetate fraction Matsunaga  
et al., 2000 
Vitis amurensis Rupr.  
(Ampelidaceae) 
Ethanol root extract Amurensin Huang et al.,2000 
Pistacia terebinthus L.  
(Anacardiaceae) 
Methanol extract of gall Masticadienolic acid, Morolic 
acid, Oleanolic acid 
Giner-Larza 
et al., 2001; Giner-Larza 
et al., 2002 
Toxicodendron radicans L. 
(Anacardiaceae) 
Ethanol fruit extract Urushiol Wagner et al.,1989 
Xylopia frutescens Aubl  
(Annonaceae) 
n-Hexane seed extract   Braga et al., 2000 
Ilex aquifolium L. (Aquifoliaceae) Ethanol leaf extract   Müller et al., 1998 
Achillea ageratifolia Boiss. 
(Asteraceae) 
  Hexadeca-2E,7Z-diene-10-ynoic 
acidpyrrolide 
Müller-Jakic et al., 1994 
Echinacea purpurea (L.) Moench 
(Asteraceae) 
Root Polyunsaturated  
isobutylamides 
Wagner et al., 1989 
Cannabis sativa L (Cannabinaceae)   Cannipren El Sohly et al., 1990 
Phyllanthus emblica (Euphorbiaceae) Diethyl ether leaf extract   Ihantola-Vormisto et al., 1997 
Cassia fistula L. (Fabaceae) Methanol fruit extract   Sunil Kumar and Müller, 1998 
Salvia aethiopis L. (Lamiaceae) Root Aethiopinone Benrezzouk et al., 2001 
Allium cepa L. (Liliaceae) Chloroform extract of 
the bulb 
Methyl-1-propenylthiosulfinate, 
Propyl-1-propenylthiosulfinate, 
Cepaenes 
Wagner et al., 1990 
Allium sativum L. (Liliaceae) Chloroform extract of 
the bulb 
Methylajoene, 
Dimethylajoene, Ajoeene, Allicin 
Sendl et al., 1992 
Ardisia japonica Blume  
(Myrsinaceae) 
Methanol extract of the 
wood 
Ardisianone A and B, Maesanin Fukuyama et al., 1993 
Punica granatum L. (Punicaceae) Seed oil Flavonoids Schubert et al., 1999 
Solanum xanthocarpum Schrad. 
(Solanaceae) 
Methanol leaf extract   Kumar et al., 2000 
Curcuma longa L. (Zingiberaceae) Petroleum ether  
extract of the rhizome 
Curcumine Ammon et al., 1992 
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A potential source for new 5-lipoxygenase inhibitors is undoubtedly provided by medicinal plants used in traditional medicine. The 
Arisia species and other Myrsinacea family produce very unusual series of dimeric benzoquinones known as ardisiaquinones, which are known 
to inhibit the enzymatic activity of 5-LOX. This feature could explain the frequent use of Ardisia species to treat inflammatory conditions. One 
such compound is Ardisiaquinone G which was isolated from Ardisia teysmanniana and is known to inhibit LOX (Yang et al., 2001; Fuuishi et 
al., 2001). The Asteraceae family is one of the richest source of LOX inhibitors and three different types of principles exhibiting remarkable 
LOX inhibition have been isolated and characterised. Helenalin, a sesquiterpene lactone, which can be isolated from several plant species of the 
Asteraceae family possess potent anti-inflammatory and antineoplastic agent. Helenalin inhibited 5-LOX (IC50 9 mM after 60 min pre-
incubation) in a concentration and time-dependent fashion in human granulocyte culture (Tornhamre et al., 2001). Polyacetylenes from 
Artemisia monosperma showed some levels of activity against LOX (Stavri et al., 2005). The third groups of LOX inhibitors in this family are 
the bornyl cinnamoyl derivatives from Verbenisa species, such as bornyl caffeate from the South American herb Verbenisa turbacensis Kunth. 
Another compound, friedelin isolated from the bark of Commiphora berryi showed significant soybean lipoxygenase (SBL) inhibitory activity 
with IC50 of 35.8μM (Kumari et al., 2011). 
Generally, an enormous number of different plant-derived compounds from various species have been found to interfere with 5-LOX 
activities. In general, it appears that lipophylic, often fatty acid-like compounds with (i.e. phenols) and without (i.e. triterpenes and 
polyacetylenes) reducing properties interfere with 5-LOX and the majority are phenolic structures including flavonoids, quinones, (that become 
hydroxylated to hydroquinones), hydroxylated coumarines, and many other polyphenols. Apparently a combination of iron-reducing and iron-
chelating properties of these phenolic compounds is responsible for 5-LOX inhibitions (Werz, 2007) 
4.0 Inhibition of nitric oxide synthetase (NOS) 
The NOS is an important enzyme involved in the regulation of inflammation, vascular tone, neurotransmission, and cancer. NO is a 
toxic free radical that can cause substantial tissue damage in high concentration. In stroke, large amount of NO is released from nerve cells and 
causes extensive damage to surrounding tissues including neurones and myocytes (Shah et al., 2011) 
The NO is biochemically generated via oxidation of the terminal guanidine nitrogen atom from L-arginine by NOS. NO is one of 
the cellular mediators of physiological and pathological process (Moncada et al., 1991; Nathan, 1992; Mollace et al., 2005). Three different 
isoforms of NOS are now recognised: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS) (Venema et al., 1997; 
Stuehr, 1999). The former two are constitutively expressed in the body, whereas the latter type is an inducible enzyme highly expressed by 
inflammatory stimuli in certain cells such as macrophages. iNOS is involved in overproduction of NO in response to pro-inflammatory 
mediators such as interleukine-1f3 (IL-1f3), tumour necrosis factor-α (TNF-α), and bacterial lipopolysaccharide (LPS). While a small 
amount of NO synthesized by eNOS and nNOS is essential for maintaining normal body function (homeostasis), a significantly increased 
amount of NO synthesized by iNOS participates in provoking inflammatory process and acts synergistically with other inflammatory 
mediators (Mollace et al., 2005). Many herbal extracts and compounds of herbal origin have shown strong inhibition of iNOS and NO over-
production (Figure 1). Search for herb-based compounds which can reduce NO production by inhibiting iNOS without affecting eNOS or 
nNOS is very desirable for anti-inflammatory agents. 
Recently, we reported the inhibition of inducible NO production by the methanol extract of Spondias mombin (Nworu et al., 2011). 
LPS-stimulated NO production by bone marrow-derived macrophages was significantly inhibited at 25 μg/ml and 100 μg/ml of the methanol 
extract (Nworu et al., 2011). Artemisinin, a sequiterpene used in the treatment of malaria was demonstrated to inhibit NO synthesis in cytokine-
stimulated human astrocytoma T67 cells (Aldieri et al., 2003). Several studies suggest that sesquiterpene lactones inhibit NO synthethase. For 
example, ambrosanolides-type sequiterpene known as cumanin isolated from Ambrosia psilostachya inhibited NO activity with an IC50 value of 
9.38 µM (Lastra et al., 2004). Ursolic acid and 2α- hydroxy ursolic acid, triterpenes from Prunella vulgaris L., inhibited NO from murine 
leukaemic monocytes macrophages (RAW 264.7) with IC50 of 17 µM and 27 µM, respectively (Ryu et al., 2000). Bigelovin, 2,3-
dihydroaromaticin, and ergolide isolated from Inula species showed potent inhibition of LPS-induced NOS in RAW 264.7 cells with IC50 values 
of 0.46 mM, 1.05 mM, and 0.69 mM, respectively (Lee et al., 2002). 
Inhibition of iNOS is not a general behaviour of flavonoids, but they inhibit NO production which means they down-regulate the 
expression of iNOS and not the activity of already produced enzymes. Flavone and several other amino-substituted flavones were reported to 
inhibit NO production (Krol et al., 1995). Flavonoids that down-regulate iNOS expression include flavones such as apigenin and oroxylin A; 
flavonols such as kaempferol and quercetin; biflavonoids such as bilobetin and ginkgetin, and some prenylated flavonoid such as sanggenons 
and kuwanon C (Kim et al., 2004). 
5.0 Inhibitions of pro-inflammatory cytokines 
Several cytokines are associated with inflammatory diseases. A number of pro-inflammatory cytokines also regulate inflammatory 
reactions either directly or by their ability to induce the synthesis of cellular adhesion molecules or other cytokines in certain cell types. The 
major pro-inflammatory cytokines that are responsible for early responses are IL1-alpha (IL-1α), IL1-beta (IL-1 f3), IL-6, and TNF-alpha 
(TNF-α). Other pro-inflammatory mediators include leukemia inhibitory factor, (LIF), interferon-gamma (IFN-γ), oncostatin M (OSM), 
ciliary neurotrophic factor (CNTF), tumour growth factor-beta (TGF-f3), granulocyte macrophage colony-stimulating factor (GM-C SF), IL-8, 
IL-11, IL-12, IL-17, IL-18, and a variety of other chemokines that chemoattract inflammatory cells. Inhibition of the expression of these 
cytokines has been demonstrated as the target for many antiinflammatory medicinal plants and their compounds (Figure 1; Table 1). Steroidal 
anti-inflammatory drugs (SAIDs) such as prednisolone and dexamethasone are also known to reduce the production of these pro-inflammatory 
cytokines (Newton, 2000). 
6.0 Modulation of pro-inflammatory gene expression 
The cellular mechanisms through which anti-inflammatory medicinal plants modulate gene expression have also been extensively 
studied. The most prominent points of cellular regulation affected by these herbs and herb-based compounds are the various protein kinases 
involved in signal transduction including protein kinase C (PKC) and mitogen activated protein kinase (MAPK) (Figure 1). Through the 
inhibition of these enzymes, DNA-binding capacity of transcription factors such as nuclear factor-ƙB (NF-ƙB) or activator protein-1 (AP-1) is 
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regulated (Kim et al., 2004). Thereby, the expression rate of the target gene is controlled. Flavonoids inhibit the enzyme activities of various 
signal transduction protein kinases (Kim et al., 2004). The best example is PKC inhibition (Ferriola et al., 1989) and protein tyrosine kinase 
inhibition (Chang and Geahlen, 1992) by various flavonoid derivatives. MAPKs are also key elements in signal transduction. In macrophages, 
LPS activates three kinds of MAPKs, extracellular signal related kinase (ERK), p38 MAPK, and Jun N-terminal kinase/ stress activated protein 
kinase (JNK/SAPK) (Weinstein et al., 1992). It was shown that a plant flavonoids, quercetin, inhibited inducible nitric oxide sythethase (iNOS) 
expression by inhibiting p38 MAPK (Wadsworth and Koop, 2001) and inhibited TNF-α -induction from LPS-induced RAW cells by inhibiting 
JNK /SAPK, leading to the inhibition of AP-1-DNA binding (Wadsworth et al., 2001). In a separate pathway, quercetin inhibited ERK 1/2 and 
p38 MAPK to regulate the post-transcriptional level of TNF-α. It has been shown that quercetin inhibited NF--ƙB activation by ERK and p38 
kinase inhibition (Cho et al., 2003). Another plant flavonoid, wogonin, inhibited monocyte chemotactic protein-1 gene expression of 12-O-
tetradecanoylphorbol 13-acetate (TPA)-induced human endothelial cells by AP-1 repression through ERK 1/2 and JNK inhibition (Chang et al., 
2001). 
Studies have shown clearly that anti-inflammatory medicinal plants inhibited the expression of various inflammation-related 
proteins/enzymes, at least partly, by suppressing activation of transcription factors such as NF-KB and AP-1 (Kim et al, 2004). These 
suppressions might be mediated via inhibition of several protein kinases involved in the signal transduction pathway. 
Table 2: Examples of some anti-inflammatory medicinal plants reported to decrease the expression of some pro-inflammatory cytokines 
Cytokine Medicinal plant Model used References 
IL-1 Curcuma longa  
Polygala tenuifolia  
Smilax glabra  
Uncaria tomentosa 
In vitro, Human  
In vitro, Murine  
Ex vivo, Human  
In vitro, Murine 
Chan, 1995 
Kim et al, 998  
Jiang and Xu, 2003  
Lemaire et al, 1999 
IL-1α Allium sativum In vitro, Human Hodge et al, 2002 
IL-1β Ampelopsis brevipedunculata  
Harpagophytum procumbens  
Ludwigia octovalvis 
Pinus maritima 
Rhus semialata 
Tabernaemontana divaricata 
In vitro, Human  
In vitro, Human  
In vitro, Human  
In vitro, Murine  
In vitro, Human  
In vitro, Human 
Kuo et al, 1999  
Fiebich et al, 2001  
Kuo et al, 1999  
Cho et al, 2001  
Kuo et al, 1999  
Kuo et al, 1999 
IL-6 Allium sativum 
Astragalus membranaceus 
Coptis spp. 
Harpagophytum procumbens 
In vitro, Human  
In vitro, Human  
In vivo, Murine  
In vitro, Human 
Hodge et al, 2002  
Shon et al, 2002  
Iizuka et al, 2000  
Fiebich et al, 2001 
TNF Acanthopanax senticosus 
Acer nikoense 
Allium sativum 
Ampelopsis 
Curcuma longa 
Dichroa febrifuga 
Harpagophytum procumbens 
Ludwigia octovalvis 
Perilla frutescens 
Polygala tenuifolia 
Polygala tenuifolia 
Rhus semialata 
Rosa davurica 
Scutellaria baicalensis 
Sinomenium acutum 
Smilax glabra 
Tabernaemontana divaricata 
Tinospora cordifolia 
Uncaria tomentosa 
Withania somnifera 
In vitro, Murine  
In vitro, Murine  
In vitro, Human  
In vitro, Human  
In vitro, Human  
In vitro, Murine  
In vitro, Human  
In vitro, Human  
In vivo, Murine  
In vitro, Murine  
In vitro, Murine  
In vitro, Human  
In vitro, Murine  
In vitro, Murine  
In vitro, Murine  
In vivo, Murine  
In vitro, Murine  
In vivo, Murine  
In vitro, Murine  
In vivo, Murine 
Yi et al, 2002 
Fujiki et al, 2003 
Hodge et al, 2002 
Kuo et al, 1999 
Chan, 1995 
Kim et al, 2000 
Fiebich et al, 2001 
Kuo et al, 1999 
Ueda and Yamazaki, 1997 
Hong et al, 2002 
Kim et al, 1998 
Kuo et al, 1999 
Kim et al, 1999 
Kim et al, 2001 
Kim et al, 1999 
Jiang and Xu, 2003 
Kuo et al, 1999 
Dhuley, 1997 
Sandoval et al, 2002 
Davis and Kuttan, 999 
IL-8 Coriolus versicolor 
Curcuma longa (Curcumin)  
Paeonia suffruticosa 
In vitro, Human  
In vitro, Human  
In vitro, Bovine 
Hsieh et al, 2002  
Hidaka et al, 2002  
Oh et al, 2003 
IL-12 Allium sativum In vitro, Human Hodge et al, 2002  
7.0 SOME NIGERIAN ANTI-INFLAMMATORY HERBS 
The use of anti-inflammatory herbs for health improvement has a long and successful history in traditional medicine in Nigeria. Many 
herbal preparations are used to treat fever and inflammation in the traditional folklore medicine. The hope of discovering novel therapeutic agents 
capable of suppressing, reducing, or relieving pain as well as inflammation is high. 
Many human and animal diseases, such as arthritic disorders, lupus erythematosus, asthma, bronchitis, inflammatory bowel disease, 
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ulcerative colitis, pancreatitis, ascities, hepatitis, cancer, infections are associated with different degrees of inflammation. Malaria and malaria 
fever can also be viewed as inflammatory disorders (Perlmann and Troye-Blomberg, 2000). The infection of the liver and the red blood cells by 
the hepatic and erythrocytic plasmodia schizonts leads to severe inflammation of hepatocytes. The clinical manifestations of malaria, fever and 
chills, are associated with the synchronous rupture of the infected erythrocytes and the release of metabolites with potent pro-inflammtory 
activities (Perlmann and Troye-Blomberg, 2000). For this reason, antipyretic and anti-inflammatory therapies are often essential in the treatment 
of malaria. This could explain the benefits and instant relive experienced by malaria patients when they use anti-inflammatory medications, 
including some herbal medications with known antiphlogistic properties. 
Table 3: Some local medicinal plants used in folklore medicine to treat inflammation, rheumatism, and fever 
Plant Family Parts of plant/ and preparation 
Gymnema sylvestre Asclepiadaceae leaf 
Acanthus montanus (Nees) Acanthaceae Infusion of leaves taken 3 times daily 
Schwenka americana (Linn) Solanaceae Whole plant; Crushed and used as poultice 
Zanha golungensis Hiern Sapindaceae Leaves; Chopped fresh leaves applied on inflamed sores 
Cardiospermum grandio  
Florum Swart 
Sapindaceae Whole plant; leaves mixed with castor oil and used orally to treat 
rheumatism and lumbago 
Paullinia pinnata Linn Sapindaceae Boil leaves and drink as desired 
Allophylus africana P. Beauv Sapindaceae Bark, root, and leaves; boiled in water and used as tea 
Achyranthes aspera Linn Amaranthaceae Whole plant; Boiled in water and used as tea 
Cythula prostrate (L.) Blume Amaranthaceae Leaves; Crushed with alcohol and used as poultice 
Alternanthera repens (L.) Kuntze Amaranthaceae Leaves; Decoction used as tea 
Monodara myristica (Gaertn) Dumal Annonaceae Leaves and bark; Chopped fresh leaves applied on fresh sores 
Ocimum basilicum Linn Labiatae Whole plant; Infusion drunk once daily 
Entadrophragma cylindricum Sprague Meliaceae Bark; macerated in alcohol and used as a drink 
Ekebergia senegalensis A. Juss Meliaceae Leaves; Infusion drunk as tea 
Lecaniodiscus cupaniodes (Planch) sapindaceae Roots and leaves; Extracts are taken orally for a long time for 
rheumatism and arthritis 
Chassalia kolly (Schumach.) Heppner Rubiaceae Leaves; Extract of bark taken as tea 
Securidaca longipedunculata Fres Polygalaceae Leaves and roots; Paste of root bark and leaves is applied 
externally on sores and to cure rheumatism 
Strophanthus hispidus Oliv Apocynaceae Leaves; Decoction taken as tea 
Astonia boonei De Wild Apocynaceae Leaves, sap, and stem bark; Topical application of the latex on 
the swollen part and leaf infusion drunk as desired 
Funtumia Africana (Benth) Stapf. Apocynaceae Leaves; Decoction taken as tea 
Abrus precatorius L. Fabaceae Leaves and stem; decoction and infusion are drunk 
Ageratum conyzoides Linn Asteraceae Leaves and flowers;frsh leaves applied on fresh sores and 
infusion drunk 
Tetrapleura tetraptera (Taub) Fabaceae Fruits; decoction and infusion drunk 
Alchornea cordifolia Euphorbiaceae Leaves; Ground leaves applied to wounds and aches 
Aspillia africana C.D. Adams Compositae Chopped leaves applied on inflamed sores 
Combretum racemosum P. Beauv Combretaceae Leaves; Leaf infusion administered orally 
Salacia pallescens Oliv Celastraceae Leaves; Crushed with alcohol and used as poultice 
Desmodium triflorum DC Papilionaceae Whole plant; a powder is made and taken with pap 
Plumbago zeylanica Linn Plumbaginaceae Roots and leaves; Decoction is drunk 
Pepperomia pellucida L. HBK Piperaceae Aerial part; Squeezed juice used for eye inflammation and 
headaches 
Anchomanes difformis Engl Araceae Aqueous decoction of the Rhizome taken orally 
Anthocleista d’jalonensis A. Chev Loganiaceae Ethanol decoction of stem bark taken orally 
Diodiu sarmentosa Swartz Rubiaceae Aqueous leaf extract taken orally and applied locally 
Hexalobus monopetalous Engl Anonaceae Aqueous infusion of root bark extract taken orally 
Mitracarpus scarber Zucc Rubiaceae Aqueous decoction of leaf extract taken orally 
Morinda lucida Benth Rubiaceae Alcoholic infusion of leaf taken orally and applied externally 
Palisota hirsuta K. Schum Commelineceae Aqueous infusion of leaf taken orally 
Pentaclethra macrophylla Benth Mimosaceae Aqueous decoction of seed taken orally 
Securidaca longipedunculata Fresen Polygalaceae Aqueous infusion of leaf taken orally and applied externally 
Strophamus hispidus Oliv Apocynaceae Aqueous decoction of leaf extract taken orally 
Emilia sonchifolia Linn Asteraceae Fresh juice squeezed from the leaves promote wound healing and 
is commonly applied to fresh wounds 
Spondias mombin Linn Anacardiace Decoction of the leaves is taken orally and commonly used to 
treat laryngitis, sour throat, and tooth decay 
Ficus exasperata Moracea Leaves of F. exasperata are mashed and prepared as poultices 
that are placed on swellings, wounds, and arthritic joints to 
relieve swelling, The leaf and stalk are used to mitigate 
itching/inflammation as well.  
5 7  
                Nworu and Akah Afr J Tradit Complement Altern Med. (2015) 12(Suppl.):52-61 
http://dx.doi.org/10.4314/ajtcam.v12i6.3S  
The treatment of rheumatic disorders (inflammation) is one area in which Nigerian traditional medical practitioners enjoy patronage and success. 
A good number of plant species are available for this purpose, and the method of usage differs from one area to another. The most common 
practice involves taking the extracts orally as decoctions or infusions; washing the inflamed part (e.g. swollen knee) with the extracts; applying 
squeezed herb as poultice on inflamed part (Akah and Nwambie, 1994; Akah et al., 2003a,b; Akah et al., 2004, 2007). Evaluation and 
understanding the mechanisms behind the anti-inflammatory activities of some of these medicinal plants has been the focus of some of our 
recent studies (Nworu et al., 2011, 2012, 2013; Okoye et al., 2013). These medicinal plants have been the focus. Some of these local medicinal 
plants which have been used in folklore medicine to treat inflammation, fever, and rheumatic ailments are shown in Table 3. 
8.0 Conclusion 
Inflammation acts as a central executor in the pathogenesis of many diseases such as rheumatoid arthritis, arteriosclerosis, myocarditis, 
infections, cancer, metabolic disorders, and many more. Monocytes and macrophages are the key players in inflammatory responses and are also the 
major sources of pro-inflammatory mediators and enzymes including tumour necrosis factor-a (TNF-α), interleukins (ILs), cyclooxygenase (COX), 
and nitric oxide synthase (NO S). These genes of pro-inflammatory mediators are strongly induced during inflammation and are 
responsible for its initiation and persistence. TNF- α and IL-1β are the cytokines that act as signalling molecules for immune cells and coordinate 
the inflammatory responses. Cyclooxygenase-2 (COX-2) is an enzyme which is necessary for the production of pro-inflammatory prostaglandins 
and thus has been a target for many present anti-inflammatory medicinal plants. Nitric oxide (NO) is a free radical that mediates many 
physiological and pathophysiological processes, including neurotransmission and inflammation. Expression of the inducible isoform of NOS 
(iNOS) in activated macrophages is mainly responsible for production of pathological concentration of NO during inflammation. Therefore 
suppression of iNO synthetase expression is an important target through which many anti-inflammatory medicinal plants mediate their activities. It 
is established that nuclear factor-κB (NF-κB) and AP-1 play the most important roles in the immune system. NF-κB is reported to regulate the 
expression of nearly all inflammatory mediators involved in inflammation. Nuclear translocation of NF- κB and AP-1 in response to various pro-
inflammatory stimuli is associated with the activation of inflammatory cascade and therefore, these transcriptional factors are primary target of 
many anti-inflammatory medicinal plants and their compounds. 
Since anti-inflammatory medicinal plant extracts are usually multi-component, it is likely that they act on multiple targets to impact 
the complex equilibrium of whole cellular networks of immune cells. This could be more favourably than agents that act on a single target since 
complementary actions on many genes might be needed to modify inflammatory disease processes. In other words, the efficacy of herbal 
therapy and herb-based anti-inflammatory compounds might depend on the perturbation of more than one target. 
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